ASk Questions in GYnecologic Oncology (ASQ-GYO) — ASQ-GYO  

Ovarian Cancer Clinical Trial

Official title: ASk Questions in GYnecologic Oncology (ASQ-GYO): A Randomized Controlled Trial of a Question Prompt List Communication Intervention in Outpatient Gynecologic Oncology Clinics

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at improving patient self-efficacy, distress, physician trust, and knowledge compared to usual care during new patient gynecologic oncology visits. Also to determine the acceptability of the ASQ-GYO QPL with new gynecologic oncology patients.

Clinical Trial Description

• Potential participants who are scheduled for a new patient appointment will be contacted via phone or email to determine if they are interested in participating.

• If a participant is interested, they will choose their preferred method of consenting (phone, email, or in person) and if they would like to complete the pre-visit survey now or at a later time prior to their appointment

• If consented, all participants will be provided with the pre-survey questionnaire. If eligible, participants will then be randomized to usual care or the intervention (ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL)

• If randomized to receive the ASQ-QYO QPL, they will be emailed this document and given a paper copy of the ASQ-GYO QPL in the waiting room prior to their visit to ensure they have received the intervention.

• Directly after the participant's visit, all participants will be asked to complete the post-visit survey on a tablet in the clinic waiting room, or via a secure link in an email within 1 week of the appointment.

• After completion of the post-visit survey and within one month of their visit, participants who were not randomized to receive the ASQ-GYO QPL will be sent the ASQ-GYO QPL via email so that they may also have access to this resource. ;

Related Conditions & MeSH terms

• Cervical Cancer
• Endometrial Cancer
• Endometrial Neoplasms
• Gestational Trophoblastic Disease
• Ovarian Cancer
• Vaginal Cancer
• Vaginal Neoplasms
• Vulvar Cancer
• Vulvar Neoplasms

• NCT number: NCT06339827
• Study type: Interventional
• Source: Barbara Ann Karmanos Cancer Institute
• Contact: Ira Winer, MD PhD
• Phone: 3135769194
• Email: iwiner@med.wayne.edu
• Status: Recruiting
• Phase: N/A
• Start date: April 4, 2024
• Completion date: May 2027